FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
Guidance on Enrichment Strategies in Trials for NDAs, BLAs
12/17/2012
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
Fujifilm Diosynth Cited Over NC Plants Microbial Contamination Controls
Camurus NDA Resubmission for Acromegaly Therapy Accepted by FDA
Class I Recall of Bolton Medicals Relay Pro Thoracic Stent Graft System
FDA Cites Charles River Endosafe Lab Over Quality System Deficiencies
Friendly Accelerated Approval Disclosures Improve Drug Understanding: Study
13 Observations in Zhejiang Hushai Inspection
Active Drug Shortages Still Trending Up
FDA Reevaluating Makarys Journal Articles, Podium Policies: DeGette
LATEST NEWS
Read More
Human Drugs
Fujifilm Diosynth Cited Over NC Plants Microbial Contamination Controls
Read More
Human Drugs
Camurus NDA Resubmission for Acromegaly Therapy Accepted by FDA
Read More
Medical Devices
Class I Recall of Bolton Medicals Relay Pro Thoracic Stent Graft System
Read More
Human Drugs
FDA Cites Charles River Endosafe Lab Over Quality System Deficiencies
FDA Webview Free Daily e-Newsletter
Free Sign-Up
